Myasthenia gravis and pregnancy: Clinical course and management of delivery and the postpartum phase;Myasthénie auto-immune et grossesse: Évolution clinique, accouchement et post-partum

Revue Neurologique

Volumn 162, Issue 3, 2006, Pages 330-338

  Ramirez, C ^a   De Seze, J ^a   Delrieu, O ^a   Stojkovic, T ^a   Delalande, S ^a   Fourrier, F ^a   Leys, D ^a   Defebvre, L ^a   Destee A ^a   Vermersch, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Delivery; Myasthenia gravis; Neonatal myasthenia gravis; Pregnancy

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DELIVERY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; NEUROLOGY; NEWBORN; NEWBORN DISEASE; ONSET AGE; PREGNANCY; PUERPERIUM; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; THERAPEUTIC ABORTION; UNIVERSITY HOSPITAL;

EID: 33645761177     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75019-6     Document Type: Article

References (42)

1. AHLSTEN G, LEFVERT AK, OSTERMAN PO, STALBERG E, SAFWENBERG J. (1992). Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy. J Child Neurol, 7: 264-269.
2. ARMENTI VT, RADOMSKI JS, MORITZ MJ, GAUGHAN WJ, PHILIPS LZ, MCGRORY CH, COSCIA LA. (2003). Report from the national transplantation pregnancy registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl, 97-105.
3. BARAKA A. (1992). Anaesthesia and myasthenia gravis. Can J Anaesth, 39: 476-486.
4. BATOCCHI AP, MAJOLINI L, EVOLI A, LINO MM, MINISCI C, TONALI P. (1999). Course and treatment of myasthenia gravis during pregnancy. Neurology, 52: 447-452.
5. BEEKMAN R, KUKS JB, OOSTERHUIS HJ. (1997). Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J Neurol, 244: 112-118.
6. BRANCH DW. (2004). Pregnancy in patients with rheumatic diseases: obstetric management and monitoring. Lupus, 13: 696-698.
7. CHABERT L, BENHAMOU D. (2004). Myasthénie, grossesse et accouchement : à propos de 10 cas. Ann Fr Anestn Reanim, 23: 459-464.
8. CIAFALONI E, MASSEY JM. (2004). The management of myasthenia gravis in pregnancy. Semin Neurol, 24: 95-100.
9. CONFAVREUX C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. (1998). Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med, 339: 285-291.
10. CZEIZEL AE, Rockenbauer M. (1997). Population-based case-control study of teratogenic potential of corticosteroids. Teratology, 56: 335-340.
11. DJELMIS J, SOSTARKO M, MAYER D, IVANISEVIC M. (2002). Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol, 104: 21-25.
12. EDEN RD, GALL SA. (1983). Myasthenia gravis and pregnancy: a reappraisal of thymectomy. Obstet Gyneco, 62: 328-333.
13. EYMARD B, MOREL E, DULAC O et al. (1989). Myasthénie et grossesse : une étude clinique et immunologique de 42 cas. Rev Neurol (Paris), 45: 696-701.
14. GENKIS G, PAPATESTAS SAE, HOROWITHZ SM, KORNFELD P. (1975). Studies in myasthenia gravis, early thymectomy. Am J Med, 58: 517-524.
15. GILMORE W, WEINER LP, CORREALE J. (1997). Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol, 158: 446-451.
16. GROB D, ARSURA EL, BRUNNER NG, NAMBA T. (1987). The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci, 505: 472-499.
17. GRONSETH GS, BAROHN RJ. (2000). Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 55: 7-15.
18. HECKMATT JZ, PLACZEK M, THOMPSON AH, DUBOWITZ V, WATSON G. (1987). An unusual case of neonatal myasthenia. J Child Neurol, 2: 63-66.
19. HOFF JM, DALTVEIT AK, GILHUS NE. (2003). Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology, 61: 1362-1366.
20. HOFF JM, DALTVEIT AK, GILHUS NE. (2004). Asymptomatic myasthenia gravis influences pregnancy and birth. Eur J Neurol, 11: 559-562.
21. HUGHES BW, MORO DE CASILLAS ML, KAMINSKI HJ. (2004). Pathophysiology of myasthenia gravis. Semin Neurol, 24: 21-30.
22. JARETZKI A, STEINGLASS KM, SONETT JR. (2004). Thymectomy in the management of myasthenia gravis. Semin Neurol, 24: 49-62.
23. KALB B, MATELL G, PIRSKANEN R, LAMBE M. (2002). Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden. Neuroepidemiology, 21: 221-225.
24. LEFVERT AK, OSTERMAN PO. (1983). Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology, 33: 133-138.
25. LINDSTROM JM, LENNON VA, SEYBOLD ME, WHITTINGHAM S. (1976). Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann N Y Acad Sci, 274: 254-274.
26. MANTEGAZZA R, BEGHI E, PAREYSON D et al. (1990). A multicentre follow-up study of 1 152 patients with myasthenia gravis in Italy. J Neurol, 237: 339-344.
27. MANTEGAZZA R, BAGGI F, ANTOZZI C et al. (2003). Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci, 1998: 413-423.
28. MASSEY JM, SANDERS DB. (1993). Single fiber electromyography in myasthenia gravis during pregnancy. Muscle Nerve, 16: 458-460.
29. MELBER D. (1988). Maternal-fetal transmission of myasthenia gravis with acetylcholine-receptor antibody. N Engl J Med, 318: 996.
30. MOK CC, WONG RW. (2001). Pregnancy in systemic lupus erythematosus. Postgrad Med J, 77: 157-165.
31. MOREL E, EYMARD B, VERNET-DER GARABEDIAN B, PANNIER C, DULAC O, BACH JF. (1988). Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases. Neurology, 38: 138.
32. NACCASHA N, GERVASI MT, CHAIWORAPONGSA T et al. (2001). Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol, 185: 1118-1123.
33. OSSERMAN KE. (1958). Myasthenia gravis. New York: Grune et Straton. p. 78-80.
34. PLAUCHE WC. (1991). Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol, 34: 82-99.
35. POLIZZI A, HUSON SM, VINCENT A. (2000). Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology, 62: 332-341.
36. ROSENBAUM RB, DONALDSON JO. (1994). Peripheral nerve and neuromuscular disorders. Neurol Clin, 12: 461-478.
37. TAGHER RJ, BAUMANN R, DESAI N. (1999). Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis. J Pediatr, 134: 233-235.
38. TO WK, CHEUNG RT. (1997). Neurological disorders in pregnancy. Hong Kong Med J, 3: 400-408.
39. VINCENT A, NEWLAND C, BRUETON L et al. (1995). Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet, 346: 24-25.
40. VINCENT A, PALACE J, HILTON-JONES D. (2001). Myasthenia gravis. Lancet, 357: 2122-2128.
41. VUKUSIC S, HUTCHINSON M, HOURS M et al. (2004). The Pregnancy In Multiple Sclerosis Group; Pregnancy In Multiple Sclerosis Group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain, 127: 1353-1360.
42. WILDER RL, ELENKOV IJ. (1999). Hormonal regulation of tumor necrosis factor-alpha, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann N Y Acad Sci, 22: 14-31.